Lead Biostatistics activities for late-stage development of medicines at GSK. Design statistical strategies and mentor teams in a high-impact role.
Responsibilities
Lead statistical planning and design for phase II and phase III clinical trials for medicines in development to treat MASH and ALD.
Provide statistical approval of trial protocols, analysis plans, and regulatory submissions.
Oversee clinical data analysis, interim reviews, and final study reporting.
Advise cross-functional teams on strategy, risk, and interpretation of results.
Line-manage and mentor statisticians to build capability.
Direct experience engaging with regulatory agencies and preparing regulatory statistical documentation.
Represent programs in senior governance meetings and external regulatory interactions.
Requirements
MSc or equivalent in Statistics, Biostatistics, Mathematics, or related quantitative discipline.
Significant experience in statistical support of clinical development, preferably within ALD and/or Metabolic disease in the pharmaceutical/biotech industry.
Expertise in the design, analysis, and interpretation of clinical studies, including biomarker development.
Demonstrated success leading and developing high-performing teams in a global environment.
Strong track record of methodological innovation and application of advanced quantitative approaches (e.g., Bayesian methods, model-informed drug development).
Experience influencing cross-functional teams and senior decision-makers.
Excellent communication skills, with the ability to articulate complex statistical concepts to diverse audiences.
Experience working with regulatory authorities and external collaborators is strongly preferred.
PhD in Statistics, Biostatistics, or related field is preferred.
Background in therapeutic areas relevant to MASH and ALD.
Track record of building statistical strategy across global development programs.
Familiarity with statistical programming in R and validated analysis environments.
Product Director leading Customer Growth at Trainline, defining strategies for paid propositions and customer lifecycle management. Driving growth through innovative monetisation and engagement approaches.
Director of Creative Engagement at University guiding creative strategies and partnerships to enhance civic and student experience. Must be an internal candidate to apply.
Responsible for business development and oversight of Global Data Capability at IFM Investors. Focus on data governance, management, and delivery while leading strategic initiatives.
Director of Fixed Asset Advisory Services at Kroll, managing client relationships, leading complex engagements, and driving business development initiatives.
M&A Director leading high - impact mergers and acquisitions at financial data provider. Driving strategic growth and managing complex transactions with board - level stakeholders.
Director of Workforce Analytics transforming workforce data into actionable insights for Healthfirst. Partnering with HR and finance to support strategic workforce planning and operational effectiveness.
Director of Credit Union System Relations leading strategic partnerships for TruStage financial services. Overseeing team dynamics and cultivating key relationships within the credit union ecosystem.
Associate Director leading multiple teams in Investor Services for SS&C, a financial services leader. Involves supervision, client relations, compliance, and operational excellence in a hybrid work environment.
Director responsible for commodity management in semiconductor equipment segment at Celestica. Leading supplier management, pricing negotiations, and strategic initiatives with 10+ years experience required.
Lead commodity management for sourcing, qualification, and relationships with suppliers at Celestica. Oversee daily operations and strategic procurement initiatives for semiconductor equipment.